Managing cytokine release syndrome and neurotoxicity with step-up dosing of mosunetuzumab in relapsed/refractory B-cell non-Hodgkin lymphoma Meeting Abstract
| Authors: | Bartlett, N. L.; Sehn, L. H.; Assouline, S.; Bosch, F.; Diefenbach, C. M.; Flinn, I.; Hong, J. Y.; Kim, W. S.; Matasar, M.; Nastoupil, L.; Schuster, S. J.; Shadman, M.; Yoon, S. S.; Bender, B.; Chu, W.; Hernandez, G.; Kwan, A.; McCall, B.; Sison, I.; Wang, C.; Wei, M. C.; Yin, S.; Yousefi, K.; Budde, E. L. |
| Abstract Title: | Managing cytokine release syndrome and neurotoxicity with step-up dosing of mosunetuzumab in relapsed/refractory B-cell non-Hodgkin lymphoma |
| Meeting Title: | 7th Annual Meeting of the Society of Hematologic Oncology (SOHO 2019) |
| Keywords: | cd20; non-hodgkin lymphoma; cd3; abcl; aggressive b-cell lymphoma |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 19 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Sep 11-14 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2019-09-01 |
| Start Page: | S247 |
| Language: | English |
| ACCESSION: | WOS:000483480700191 |
| DOI: | 10.1016/j.clml.2019.07.151 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: ABCL-149 -- Source: Wos |
